Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell

Pancreas transplantation and islet transplantation are now established in the treatment of IDDM. Several trials of stem cell‐derived cell transplantation therapy are underway and may offer an alternative to the limited supply of donor islets in the near future. This article summarizes recent develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Toshihiro, Fujikura, Junji, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
JDI Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858099/
https://www.ncbi.nlm.nih.gov/pubmed/32654418
http://dx.doi.org/10.1111/jdi.13358
_version_ 1783646582792519680
author Nakamura, Toshihiro
Fujikura, Junji
Inagaki, Nobuya
author_facet Nakamura, Toshihiro
Fujikura, Junji
Inagaki, Nobuya
author_sort Nakamura, Toshihiro
collection PubMed
description Pancreas transplantation and islet transplantation are now established in the treatment of IDDM. Several trials of stem cell‐derived cell transplantation therapy are underway and may offer an alternative to the limited supply of donor islets in the near future. This article summarizes recent developments in transplantation therapy for diabetes as well as research on the use of stem cells for complications of diabetes.[Image: see text]
format Online
Article
Text
id pubmed-7858099
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78580992021-02-05 Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell Nakamura, Toshihiro Fujikura, Junji Inagaki, Nobuya J Diabetes Investig JDI Updates Pancreas transplantation and islet transplantation are now established in the treatment of IDDM. Several trials of stem cell‐derived cell transplantation therapy are underway and may offer an alternative to the limited supply of donor islets in the near future. This article summarizes recent developments in transplantation therapy for diabetes as well as research on the use of stem cells for complications of diabetes.[Image: see text] John Wiley and Sons Inc. 2020-08-27 2021-02 /pmc/articles/PMC7858099/ /pubmed/32654418 http://dx.doi.org/10.1111/jdi.13358 Text en © 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle JDI Updates
Nakamura, Toshihiro
Fujikura, Junji
Inagaki, Nobuya
Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
title Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
title_full Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
title_fullStr Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
title_full_unstemmed Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
title_short Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
title_sort advancements in transplantation therapy for diabetes: pancreas, islet and stem cell
topic JDI Updates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858099/
https://www.ncbi.nlm.nih.gov/pubmed/32654418
http://dx.doi.org/10.1111/jdi.13358
work_keys_str_mv AT nakamuratoshihiro advancementsintransplantationtherapyfordiabetespancreasisletandstemcell
AT fujikurajunji advancementsintransplantationtherapyfordiabetespancreasisletandstemcell
AT inagakinobuya advancementsintransplantationtherapyfordiabetespancreasisletandstemcell

Ejemplares similares